Future of Medicare drug price negotiations under new administration: 5 things to know
(By Alexandra Murphy for Becker’s Hospital Review) As President-elect Donald Trump prepares to take office, the future of Medicare’s drug
Read More(By Alexandra Murphy for Becker’s Hospital Review) As President-elect Donald Trump prepares to take office, the future of Medicare’s drug
Read More(By Craig Paloskey for The Kaiser Family Foundation published September 13, 2024) Allowing Medicare to negotiate drug prices on behalf
Read More(By Juliette Cubanski for The Kaiser Family Foundation Published: Aug 20, 2024) The Inflation Reduction Act of 2022 (the Act),
Read More(Tammie Smith for The Kaiser Family Foundation published August 14, 2024) Among the 167 million people with employer-sponsored insurance in
Read More(By Chris Lee and Craig Palosky for The Kaiser Family Foundation published May 15, 2024) A new KFF poll finds
Read More(By Rachel Cohrs for STAT) WASHINGTON — President Biden wants to more than double the size of Medicare’s new drug
Read More(Chris Lee for The Kaiser Family Foundation published January 31, 2024) Under the Inflation Reduction Act, the federal government for
Read More(By Juliette Cubanski for The Kaiser Family Foundation Published: Jan 31, 2024) The Inflation Reduction Act of 2022 (the Act),
Read More(By Sydney Lupkin for NPR) For the first time, Medicare is beginning to negotiate the prices of prescription drugs. Despite
Read More(By Juliette Cubanski, Anthony Damico, and Tricia Neuman for The Kaiser Family Foundation Published: Sep 26, 2023) Medicare recently announced
Read More